Learn More
Medchemexpress LLC NVP-BSK805 dihydrochloride | 1942919-79-0 | 99.0% | 563.47 | 25 MG

Supplier: Medchemexpress LLC 25MGHY14722A
NVP-BSK805 dihydrochloride is an ATP-competitive inhibitor primarily targeting JAK2, with high selectivity over other JAK family members like JAK1, JAK3, and TYK2. It effectively suppresses the growth of JAK2V617F-bearing acute myeloid leukemia cell lines and blocks STAT5 phosphorylation. This compound also enhances the sensitivity of drug-resistant cancer cells to certain treatments by improving P-gp inhibitory activity.
- Potent ATP-competitive JAK2 inhibitor
- Selective inhibition over JAK1, JAK3, and TYK2
- Suppresses JAK2V617F-bearing acute myeloid leukemia cell growth
- Blocks STAT5 phosphorylation
- Improves P-gp inhibitory activity
- Increases sensitization of drug-resistant cancer cells to treatments
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.